RESEARCH / PARTICIPATIONBack to the library
← Find a study
Recruiting · registry status

Testing a probiotic for Parkinson’s symptoms

Researchers investigate a probiotic containing Clostridium butyricum bacteria for movement and other symptoms in Parkinson’s.

Testing a treatment or activity · Study reference: NCT06548256

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Looking for volunteers

Start (reported actual date)
2023-10-31
Main measurements finished (planned)
2026-12-31
Study finished (planned)
2026-12-31

Planned dates can move. A study finishing does not tell us when a paper will be published.

No results summary has been confirmed in the registry records we imported. See connected papers below; we keep checking after recruitment ends.

Changes we have recorded
  • 2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Ages 20 years to 90 years · Does not accept healthy volunteers

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: all

Inclusion Criteria: * Male or female over 20 years old, diagnosed with Parkinson's disease. Exclusion Criteria: * People with Parkinson's disease Dementia, or Lactose Intolerance
Full study name & original research details

Official study title

The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease

Original description

This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease

Further description from the registry

The physician will explain the trial procedures in the outpatient, and then obtain the written informed consent to start the interview. And randomly divided into experimental and observation groups, and according to the timing of taking Miyarisan, scale evaluation and sample collection.

Conditions reported: Clostridium Butyricum Miyairi; Parkinson Disease

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

Study type
Interventional
Interventions
Miyarisan-BM (Clostridium Butyricum Miyairi)
Phases
NA
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Start date reported by registry
2023-10-31 (actual)

Registry updated: 2024-08-12 · Status last verified by the registry submitter: 2024-01

Registry records retrieved 2026-10-13 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Yang-Pei Chang, M.D.; MSc. · 886-7-2911101 · cyp905@gmail.com

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Kaohsiung Medical Univeristy Hospital

Kaohsiung City, Taiwan

Recruiting

Yang-Pei Chang, M.D.; MSc, · 886-7-2911101 · cyp905@gmail.com

Facility not reported

Taiwan

Status not reported

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.